Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F20HL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,990
Award facts
- Contract value 100% obligated
- $81,989.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ondansetron HCl 4 mg tablets (500 count) with a contract value of approximately $82K. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by January 7, 2026, with performance executed from the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC encompasses a broad range of pharmaceutical products including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains. Ondansetron, an anti-nausea medication commonly used in medical settings, represents a routine pharmaceutical supply requirement supporting military treatment facilities and veterans' healthcare operations. The contractor's portfolio demonstrates consistent capability to fulfill competitive federal medical supply requirements through open competition across various therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26F20HL?
SPE2DR26F20HL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F20HL worth?
The government has obligated $81,990 on SPE2DR26F20HL.
Is contract SPE2DR26F20HL an order under another contract?
Yes. SPE2DR26F20HL is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20HL competed?
The extent of competition for SPE2DR26F20HL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award